Nucleus Analytics

Clinical development study teams must contend with many challenges and complexities in developing and executing clinical trials. Some challenges are directly related to, or are impacted by, laboratory considerations. For example, study teams are asked to evaluate decentralized trial designs, informed consent tracking, and future use of patient samples. They are asked to work with niche laboratories, point of care (POC) laboratory devices, and other technologies to enable patient-centric trials.